Find Academic Supervisors

Lynda LisabethView profile

Professor

• Stroke Epidemiology
• Health Disparities
• Hispanic Health
• +6 more

Lynda Lisabeth, PhD, MPH serves as Interim Dean of the University of Michigan School of Public Health and holds dual appointments as Professor of Epidemiology and Research Professor of Neurology. Her primary academic home is the Department of Epidemiology within the School of Public Health, where she leads significant research on stroke epidemiology with emphasis on health disparities. Her research focuses on stroke risk and outcomes, post-acute stroke care, informal caregiving, stroke healthcare utilization, sleep-disordered breathing after stroke, and social determinants of health. She co-leads the Brain Attack Surveillance in Corpus Christi (BASIC) Project, a longstanding population-based stroke surveillance study operating since 2000 that examines ethnic-specific stroke trends and outcomes in Mexican American and non-Hispanic white populations. Her work consistently demonstrates how stroke uniquely impacts women and Hispanic populations through intersectional analyses of social, environmental, and biological factors. Analysis of her 15 most recent publications reveals consistent focus on ethnic disparities in stroke outcomes, sleep disorders following stroke, longitudinal recovery patterns, and the role of neighborhood characteristics in post-stroke recovery. Her research employs population-based surveillance methods, longitudinal cohort designs, and innovative approaches to measuring social determinants of health. Lisabeth has secured substantial funding for her research initiatives, particularly through the BASIC Project infrastructure which supports multiple concurrent studies on post-stroke sleep, rehabilitation, and caregiving. Her work demonstrates strong interdisciplinary collaboration across epidemiology, neurology, sleep medicine, and health services research. She maintains an active research team investigating multiple aspects of post-acute care following stroke, with particular attention to Mexican American communities. Her laboratory work integrates population surveillance with detailed clinical assessments to understand mechanisms behind observed disparities.

Olivia HalabickyView profile

Assistant Professor

• Environmental Exposures
• Child Health and Neurodevelopment
• Global Health Equity
• +6 more

Dr. Olivia Halabicky is an Assistant Professor at the University of Michigan with dual appointments in the School of Nursing and School of Public Health, specifically in the Department of Nutritional Sciences and Department of Health Behavior and Clinical Sciences. Her research focuses on children's environmental health, examining how early life exposures to toxicants, adversity, and nutrition shape neurodevelopment and health trajectories. Dr. Halabicky earned her PhD in Nursing from the University of Pennsylvania (2021), MSc in Nursing with focus on Child Health and Wellbeing from Trinity College Dublin (2018), and BSN from Saginaw Valley State University (2015). Her research program investigates how environmental exposures at sensitive developmental periods influence health disparities, with particular emphasis on lead exposure and its effects on neurodevelopment, physiological stress responses, and long-term health outcomes. She employs interdisciplinary methods from nursing, environmental epidemiology, and developmental sciences, primarily working within the ELEMENT cohort, a Mexican birth cohort followed for over 30 years. Analysis of Dr. Halabicky's publication record reveals a strong focus on environmental toxicants, particularly lead exposure, and their impacts on child development across multiple domains including neurocognitive function, physiological stress markers, sleep patterns, and cardiovascular health. Her work consistently examines how social factors like parental education modify these exposure-outcome relationships, highlighting the intersection of environmental and social determinants of health. Scholar, Michigan Program for Advancing Cultural Transformation (M-PACT), University of Michigan, 2024 Center Scientist, Michigan Lifestage Environmental Exposures and Disease (M-LEEaD) Center, 2024-2025 Award, Rising Star, Rho Chapter Sigma Theta Tau International, 2023 Fellow, Early Career Interdisciplinary Scholars, Society for Research in Child Development, 2023 Future of Nursing Scholar, Robert Wood Johnson Foundation, 2018-2021 Award, Young Alumni, Saginaw Valley State University, 2018 Dr. Halabicky serves as Principal Investigator on multiple research grants including a Center Scientist Award from the Michigan Lifestage Environmental Exposures and Disease (M-LEEaD) Center and a National Institute of Nursing Research grant (L30 NR020943) examining early life lead and psychosocial co-exposures on adolescent physiological stress. While she is not currently accepting new PhD students, she has extensive teaching and mentorship experience in both nursing and public health programs, delivering guest lectures on environmental exposures and child health. Her professional affiliations include the Center for Global Health Equity at the University of Michigan, Society for Pediatric and Perinatal Epidemiologic Research, Alliance of Nurses for Healthy Environments, International Society for Environmental Epidemiology, Society for Research in Child Development, Midwest Nursing Research Society, and Sigma Theta Tau International.

Simon DucharmeView profile

Associate Professor

• neuropsychiatry
• frontotemporal dementia
• biomarkers
• +4 more

Dr. Simon Ducharme is an Associate Professor in the Department of Psychiatry at McGill University's Faculty of Medicine and a Researcher at the Douglas Research Centre. He serves as the Scientific Director of the Centre for Precision Psychiatry at the McGill University Health Centre (MUHC) and leads the FTD & Neuropsychiatry Lab within the Aging, Cognition, and Alzheimer's Disease Theme-Based Group. Dr. Ducharme also holds the position of Associate Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) within the Brain Repair and Integrative Neuroscience (BRaIN) Program at the Montreal Neurological Institute. Dr. Ducharme earned his medical degree from Université de Montréal, completed a Master's at McGill University, Psychiatry residency at McGill in 2012, and a fellowship in Behavioral Neurology and Neuropsychiatry at Harvard University in 2014. He is board-certified in Behavioral Neurology and Neuropsychiatry by the United Council for Neurological Subspecialties and works as a Neuropsychiatrist at the Douglas Mental Health Institute, with a clinical specialty in frontotemporal dementia. His research program focuses on developing novel neuroimaging diagnostic and prognostic biomarkers for frontotemporal dementia, with particular emphasis on distinguishing behavioral variant FTD from primary psychiatric disorders. Dr. Ducharme's work combines translational studies using structural and functional imaging to improve early diagnostic markers for neurodegenerative diseases. His research spans multiple areas including precision psychiatry, neuropsychiatry, biomarker development, and the application of artificial intelligence to identify better treatments for psychiatric disorders. Dr. Ducharme serves as the Montreal site Principal Investigator for the Genetic Frontotemporal Dementia Initiative (GENFI) study and the FTD team leader for the Canadian Consortium on Neurodegeneration in Aging (CCNA). He is also the current chair of the American Neuropsychiatric Association committee on research and oversees multiple clinical trials for Alzheimer's disease and related dementias. Research Leadership: Scientific Director of the Centre for Precision Psychiatry, Montreal site PI for GENFI, FTD team leader for CCNA Professional Recognition: FRQS-funded Senior Clinical Research Scholar, recipient of over 35 awards including the 2013 Career Development Award from the American Neuropsychiatric Association Clinical Focus: Neuropsychiatry with specialty in frontotemporal dementia, working at the Cognitive Health Clinic Dr. Ducharme's work bridges clinical practice and research, with significant contributions to understanding the neurobiological basis of neuropsychiatric disorders and developing better diagnostic approaches for complex cases where psychiatric symptoms may mask underlying neurodegenerative conditions.

• Autism
• Developmental Disorders
• Neuroscience
• +3 more

Mayada Elsabbagh, PhD, is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and an Associate Professor in the Department of Neurology and Neurosurgery, Faculty of Medicine and Health Sciences, McGill University. She leads research in autism and developmental disorders through the Child Health and Human Development Program at RI-MUHC. Senior Scientist, RI-MUHC Associate Professor, McGill University Director, Transforming Autism Care Consortium Her research focuses on early brain function markers for autism, developmental pathways, and knowledge translation. She works on accelerating scientific discoveries into community impact, with global initiatives in low- and middle-income countries. Recent publications address autism genetics, caregiver training programs, neuroimaging in infants, and cross-national health policies. Articles span 2025-2023, emphasizing genomic studies, early intervention frameworks, and emotional-behavioral comorbidity.

Gavin BuzzaView profile

Lecturer

• Exercise Physiology
• Sports Science
• Muscle Physiology
• +5 more

Gavin Buzza is a Lecturer in Exercise Science at Charles Sturt University, affiliated with the School of Allied Health, Exercise and Sports Sciences. He has taught undergraduate subjects such as Exercise Physiology, Human Anatomy, and Chronic Disease Management, and has international teaching experience at Wuhan Sports University. Specializations: Clinical Exercise Physiology, Resistance Training at Altitude Accreditations: Accredited Exercise Physiologist (ESSA), Accredited Sports Scientist (ESSA), Level 1 Strength and Conditioning Coach (ASCA) His research focuses on exercise physiology, oxygen utilization, and tissue oxygenation , with collaborations in China. Recent work includes studies on paramedicine student fitness, brain cancer survivor rehabilitation, and oxygenation dynamics in trained athletes. Research Trends: Analysis of endurance and resistance training effects on muscle and brain oxygenation, aging physiology, and evidence-based digital health interventions. Collaborations: Engaged with institutions in China on altitude training studies.

Christopher GreggView profile

Professor

• Neurogenetics
• Genomics
• Epigenetics
• +8 more

Christopher Gregg is a Professor of Neurobiology and Adjunct Assistant Professor at the University of Utah, with affiliations in Human Genetics. His research bridges neuroscience and genomics. Research interests include neurogenetics, epigenetics, and the interplay between genes and environment in shaping behavior. His lab explores genomic imprinting, regulatory elements in social behaviors, and cancer resistance mechanisms. Recent publications focus on evolutionary genomics, allele-specific expression in the brain, and behavioral development linked to epigenetic regulation. Scientific awards : Eppendorf Prize (2010) for work on parental brain control Technologies developed: 3D printing, computer vision, and machine learning for high-throughput behavioral screening in mice.

Alexandra Castillo-RuizView profile

Assistant Professor

• Developmental Neuroscience
• Neurobiology of Birth
• Microbiota-Brain Axis
• +3 more

Dr. Alexandra Castillo-Ruiz is an Assistant Professor in the Department of Psychology at Michigan State University, specializing in Behavioral Neuroscience. Her research focuses on the critical role of birth as a biological event that shapes brain and behavioral development in placental mammals. PhD in Psychology and Ecology, Evolutionary Biology & Behavior from Michigan State University MA in Psychology from Michigan State University BS in Biology from Agrarian La Molina University Dr. Castillo-Ruiz's work investigates how birth-associated factors like microbiota colonization, birth mode (Cesarean vs. vaginal), and hypoxia influence neurodevelopment. Using mouse models, her lab explores neuroinflammatory responses, epigenetic mechanisms, and hormonal changes during the perinatal period. Her recent publications highlight microbiota-brain interactions, birth-induced immune activation, and long-term neuroendocrine consequences of birth mode differences. Key themes include developmental plasticity, neuroimmune coupling, and evolutionary conserved perinatal processes. The Castillo-Ruiz Lab serves as an interdisciplinary research hub at Michigan State University, employing cellular, molecular, and behavioral techniques to study neurodevelopmental programming by birth events. Their work has clinical relevance for understanding impacts of peripartum antibiotic use and Cesarean delivery rates.

Timothy WaxweilerView profile

Associate Professor

• Radiation Oncology
• Cancer Treatment
• Brain Tumors
• +6 more

Timothy Waxweiler, MD is an Associate Professor of Clinical Practice in the Department of Radiation Oncology at the University of Colorado Anschutz Medical Campus School of Medicine. He practices at multiple locations including UCHealth Radiation Oncology - Anschutz Medical Campus, UCHealth Radiation Oncology - Cherry Creek Medical Center, and Rocky Mountain Gamma Knife Center. Dr. Waxweiler is affiliated with University of Colorado Hospital and the University of Colorado Cancer Center. Education: MD from Emory University School of Medicine (2011) Undergraduate: BSE from University of Michigan (2006) Internship: Presbyterian-St Luke's Medical Center Program (2012) Residency: University of Colorado, Chief Resident, Radiation Oncology (2016) Board Certification: Radiation Oncology (2017) Dr. Waxweiler's clinical interests span the full spectrum of radiation oncology, with particular expertise in treating brain, spine, prostate, breast, and thoracic tumors. His research focuses on innovative radiation therapy techniques and their application across various cancer types. He is especially interested in functional avoidance radiation therapy, brain metastases management, and novel combinations of radiation with immunotherapeutic agents. Analysis of Dr. Waxweiler's publication record reveals a strong focus on clinical radiation oncology research with emphasis on brain metastases, thoracic radiation therapy, and head and neck cancer. His work often involves multi-institutional collaborations and clinical trials exploring novel therapeutic approaches. A significant portion of his research examines functional avoidance techniques in radiation therapy, particularly using 4DCT-ventilation mapping for thoracic treatments. American Society for Radiation Oncology (ASTRO), Member Dr. Waxweiler adheres to a patient-centered care philosophy that prioritizes listening to patients and families and incorporating their values into evidence-based treatment planning. His primary practice location is at Cherry Creek Medical Center, with additional time spent at the Anschutz Medical Campus location. He treats all forms of cancer and benign conditions requiring radiation therapy, with particular expertise in brain, spine, prostate, breast, and thoracic tumors.

• Adolescent Psychiatry
• Substance Use Disorders
• Cognitive Neuroscience
• +4 more

Dr. Patricia Conrod is a Professor of Psychiatry at the Université de Montréal and holds the Canada Research Chair in Mental Health and Prevention . She leads the Venture Lab at CHU Sainte-Justine, focusing on adolescent brain development, substance use disorders, and mental health prevention strategies. Her research spans neuroimaging, personality-targeted interventions, and multimodal studies of cannabis effects. Department of Psychiatry and Addiction Department of Pediatrics Co-Director, IMAGINE Center Director, Neuroscience and Mental Health Strategy (SENSUM) Her work combines genetic, environmental, and neuroimaging approaches to study risk factors for addiction and mental health problems. Recent projects include the CoVenture Trial (10-year cannabis-brain study), CUSP Trial (pan-Canadian underage substance prevention), and PsyVenture (psychosis-risk cannabis prevention). Key scientific contributions include 15+ peer-reviewed articles in 2024-2025 on topics like screen time effects , sleep-psychosis links , and cross-disorder cortical patterns . Awards include Tier 1 Canada Research Chair and Quebec Research Fund Fellowships . Dr. Conrod's PreVenture Program has trained global professionals and demonstrated 35% annual reduction in substance use disorders through personality-targeted interventions. Current initiatives include adapting programs for university students ( UniVenture ) and digital health applications ( DigiVenture ).

• Alzheimer's Disease
• Dementia Research
• Neurodegeneration
• +7 more

Professor Bettina Platt holds the Chair in Translational Neuroscience at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition. With a distinguished career spanning from her 1997 appointment at the university, she leads a multi-disciplinary research team investigating aspects of brain function and malfunction from molecular to systems levels. Her work bridges basic neuroscience with clinical applications, particularly in dementia research. Graduated with distinction from University of Mainz, Germany Received PhD (Dr rer. nat.) from University of Düsseldorf, Germany Completed prestigious European Fellowship at University of Leeds Professor Platt's research focuses on Alzheimer's disease and other dementias, mechanisms of neuronal plasticity, neurodegeneration, and neuroprotection. Her laboratory combines histology, immunocytochemistry, electrophysiological and imaging techniques, behavioral studies, and EEG recordings to investigate disease mechanisms and potential treatments. Her work spans from single molecule to systems level analysis, with particular emphasis on translational approaches that can inform clinical practice. Analysis of Professor Platt's recent publications (2022-2025) reveals a strong focus on Alzheimer's disease mechanisms, particularly the relationship between metabolic disorders and neurodegeneration. Her work extensively utilizes transgenic mouse models (PLB, rTg4510, 5XFAD) to study cognitive phenotypes, neuroinflammation, and molecular pathways. A notable trend is her increasing investigation of EEG and neuroimaging techniques for dementia diagnosis and progression monitoring, alongside studies on dietary interventions and pharmacological approaches targeting diabetes-Alzheimer's connections. Fellow of the Society of Biology (FRSB) Professor Platt has served as Research Director for numerous large research initiatives, many co-funded by the pharmaceutical industry and Scottish government. Her extensive national and international collaborations have integrated diverse research strategies across imaging, drug discovery, electronics, and computer science. She actively supervises PhD students in Biomedical Sciences and is accepting new PhD candidates for research in her areas of expertise. As head of a multi-disciplinary research team, Professor Platt oversees projects spanning Alzheimer's disease mechanisms, frontotemporal dementia, neuronal plasticity, and CNS therapeutics. Her laboratory utilizes advanced techniques including in vivo and in vitro electrophysiological recordings, PET/CT and MRI imaging, behavioral assessments, and molecular analyses. Her collaborative network includes researchers across Aberdeen University, international academic institutions, and industry partners focused on dementia research and drug development.

Kurt SchillingView profile

Assistant Professor

• Medical Imaging
• Biomedical Engineering
• Neuroimaging
• +3 more

Kurt Schilling is a Research Assistant Professor at Vanderbilt University , affiliated with both the Department of Electrical and Computer Engineering and the Vanderbilt Institute for Surgery and Engineering (VISE) . He is a member of the Medical-image Analysis and Statistical Interpretation (MASI) Lab , working under the mentorship of Bennett Landman . PhD in Biomedical Engineering (2020), Vanderbilt University B.S. in Biomedical Engineering, University of Toledo Research Interests focus on advanced MRI techniques for mapping brain microstructure and connectivity, particularly using diffusion MRI to study aging and neurodegenerative diseases. His work spans image acquisition , processing algorithms , and biomedical modeling to improve diagnostic accuracy and understanding of brain networks. Recent Publications address critical challenges in diffusion MRI harmonization , white matter functional networks , and machine learning applications for neuroimaging across aging cohorts. Key contributions include deep learning pipelines for bias correction and quantitative T1 mapping comparisons.

Gail RattingerView profile

Professor

• Health Outcomes
• Neurodegenerative Diseases
• Pharmacoepidemiology
• +3 more

Gail Rattinger is a Professor in the Department of Pharmaceutical Sciences at the School of Pharmacy and Pharmaceutical Sciences, Binghamton University. She previously held roles as Associate Dean for Academic Affairs and Assessment, and Vice Dean at the same institution. Her career includes tenure as Director of the Pharmaceutical Research Computing Center at the University of Maryland School of Pharmacy, and as Associate Professor at Fairleigh Dickinson University. She holds a BA in Chemistry from Occidental College (1979), a PhD in Physical Inorganic Chemistry from the University of Illinois (1984), a PharmD from the University of California, San Francisco (2007), and completed a postdoctoral fellowship in pharmacoeconomics at the University of Maryland (2007–2009). She is licensed as a pharmacist in New Jersey and Maryland. Dr. Rattinger’s research focuses on unmet healthcare needs of geriatric and vulnerable populations, particularly dementia care and its socioeconomic impacts. Her work includes studies on dementia progression using the Cache County Study cohort, examining risk factors like neurotrophin genetics, sleep disturbances, and modifiable lifestyle factors. She also investigates HIV testing access in underserved communities and opioid use disorder interventions. Her research has been funded by NIH (K12 grants) and state agencies. Her academic leadership emphasizes curricular innovation in healthcare education, advocating for interprofessional teamwork and evidence-based practice. She collaborates on projects addressing medication safety in long-term care, fall risk assessment, and integrating social determinants of health into clinical training. Her recent work explores disparities in PrEP availability and college student substance misuse trends. Dr. Rattinger’s contributions span academic administration, clinical research, and public health policy. She serves as a key figure in advancing geriatric pharmacotherapy research and training the next generation of healthcare professionals through structured learning initiatives and assessment frameworks.

Benedict C. AlbensiView profile

Professor

• Alzheimer's Disease
• Neurodegenerative Diseases
• Inflammation
• +4 more

Benedict C. Albensi is a Professor and Chair of the Department of Pharmaceutical Sciences at the Barry and Judy Silverman College of Pharmacy, Nova Southeastern University. He holds a Ph.D. in Neuroscience from the University of Utah's Medical School (1995) and has held appointments at institutions including Georgetown University, Case Western Reserve University, and the Cleveland Clinic. His research focuses on Alzheimer’s disease (AD), mitochondrial dysfunction, and neuroinflammation. Key research interests include understanding the role of nuclear factor kappa B (NF-κB) in memory formation, sex-based differences in AD pathology, and mitochondrial bioenergetics. He has pioneered studies showing NF-κB’s role in synaptic plasticity and mitochondrial deficits preceding AD’s hallmark plaques. His work has been recognized through top 1% Expertscape rankings in Alzheimer's Disease, tauopathies, and NF-κB signaling. Current lab efforts explore novel therapies like mitochondrial transplantation, estradiol’s neuroprotective effects, and AI applications for early AD detection. Student opportunities exist across PharmD, MS/PhD, and postdoctoral levels, focusing on AD mechanisms, clinical trials, and animal models. Collaborations span dementia prevention, neuroimaging, and nutritional interventions.

Jakob SkarabotView profile

Senior Lecturer

• Neuromuscular Physiology
• Motor Unit Discharge
• Exercise-Induced Muscle Damage
• +3 more

Dr. Jakob Škarabot is a Senior Lecturer in Neuromuscular Physiology at Loughborough University. His research focuses on motor unit discharge patterns, neuromuscular adaptations to resistance training, sex differences in fatigability, and innovative rehabilitation techniques. He is affiliated with the National Centre for Sport and Exercise Medicine and has contributed to publications on topics such as high-density surface electromyography (HDEMG), muscle damage biomarkers, and neuromodulation via tDCS. Education: BSc in Kinesiology (University of Ljubljana), MSc in Sport Science (University of Jyväskylä), PhD in Neurophysiology (Northumbria University) Academic Career: Doctoral Prize Fellow (2019), Lecturer (2020), Senior Lecturer (2024) His recent work examines muscle-specific HDEMG decomposition efficiency, sex-based neuromuscular aging disparities, and interventions to enhance recovery in athletes. While no formal awards or student supervision details are listed, his publications highlight collaborations in sports performance and health-related research.

Brian McCabeView profile

Associate Professor

• Motor Neuroscience
• Neurodegenerative Diseases
• Drosophila Genetics
• +3 more

Brian McCabe is an Associate Professor and Director of the Laboratory of Neural Genetics and Disease at the École Polytechnique Fédérale de Lausanne (EPFL). He holds roles as Director of the Brain Mind Institute (BMI) and serves on the PhD program committee for the Neuroscience Doctoral Program (EDNE). His research focuses on motor system neurobiology, leveraging Drosophila genetics to study synapse function, circuit dynamics, and neurodegenerative disorders such as ALS and SMA. McCabe’s lab employs advanced neurogenetic tools and in vivo imaging to dissect molecular mechanisms underlying motor circuit dysfunction across aging and disease. Education details are not explicitly provided in the text. His current academic positions include: Associate Professor, School of Life Sciences (SV) Director, Brain Mind Institute (BMI) PhD Program Committee Member, Doctoral Program Neuroscience Research Interests: Motor synapse maintenance and plasticity Neurodegenerative disease modeling in Drosophila Age-related synaptic decline Genetic conservation in motor neuron disorders His lab integrates molecular genetics, electrophysiology, and behavioral analysis to study how synapses and circuits adapt during health and disease. Publications reflect a focus on synaptic biology, aging mechanisms, and neurodegenerative pathways. Grants and collaborations support his work on motor system dysfunction. He advises multiple PhD students and oversees lab members including postdoctoral scientists and technicians. Laboratory activities include developing genetic tools (e.g., pBID vectors) and sharing reagents with the scientific community. The lab is part of EPFL’s Brain Mind Institute, emphasizing interdisciplinary research in neuroscience.